These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes. Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474 [TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine. Thakkar SG; Warnken ZN; Alzhrani RF; Valdes SA; Aldayel AM; Xu H; Williams RO; Cui Z J Control Release; 2018 Dec; 292():111-118. PubMed ID: 30339906 [TBL] [Abstract][Full Text] [Related]
19. Immune-Focusing Properties of Virus-like Particles Improve Protective IgA Responses. Onodera T; Hashi K; Shukla RK; Miki M; Takai-Todaka R; Fujimoto A; Kuraoka M; Miyoshi T; Kobayashi K; Hasegawa H; Ato M; Kelsoe G; Katayama K; Takahashi Y J Immunol; 2019 Dec; 203(12):3282-3292. PubMed ID: 31704880 [TBL] [Abstract][Full Text] [Related]
20. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus. Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]